Advertisement
IN Stocks

GENESYS.BO stock plunges 16.87% on May 12, 2026 BSE close

Key Points

GENESYS.BO stock crashed 16.87% to INR 219.1 on May 12, 2026 BSE close.

Meyka AI rates the stock D+ with Strong Sell recommendation due to negative cash flow.

Technical indicators show extreme oversold conditions with RSI at 38.24 and Williams %R at -96.23.

Year-to-date decline of 47.56% reflects severe fundamental deterioration and weak profitability metrics.

Be the first to rate this article

GENESYS.BO stock crashed hard on May 12, 2026, losing 16.87% to close at INR 219.1 on the BSE. Genesys International Corporation Limited, a Mumbai-based geospatial services provider, faced severe selling pressure as the stock hit a day low of INR 217.05. The sharp decline reflects growing investor concerns about the company’s financial health and operational performance. With a market cap of INR 9.6 billion and trading volume of 31,728 shares, GENESYS.BO stock has become one of the market’s notable losers. The company’s recent performance metrics paint a troubling picture for shareholders.

Advertisement

GENESYS.BO Stock Price Collapse and Technical Breakdown

GENESYS.BO stock opened at INR 230 but quickly deteriorated throughout the session. The stock fell INR 44.45 from its previous close of INR 263.55, marking a severe single-day reversal. The day’s high of INR 232.8 proved unreachable as sellers dominated the market.

Technical indicators confirm the weakness. The Relative Strength Index (RSI) sits at 38.24, signaling oversold conditions. The MACD histogram shows negative momentum at -1.26, while the Williams %R indicator at -96.23 suggests extreme selling pressure. The stock trades below its 50-day moving average of INR 393.13 and significantly below its 200-day average of INR 549.67, indicating a sustained downtrend.

Meyka AI Rating and Fundamental Concerns

Meyka AI rates GENESYS.BO with a grade of B and a suggestion to HOLD, though this masks deeper concerns. The company received a D+ rating with a Strong Sell recommendation based on multiple financial metrics. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

The valuation metrics reveal significant red flags. GENESYS.BO stock trades at a PE ratio of 15.78 with an EPS of INR 14.55. However, the price-to-book ratio of 1.40 and price-to-sales ratio of 3.01 suggest the stock remains expensive relative to fundamentals. Free cash flow per share is negative at INR -6.41, indicating the company burns cash despite generating revenue of INR 76.07 per share.

Market Sentiment and Trading Activity

Trading Activity: Volume declined significantly with only 31,728 shares traded against an average of 62,494. This 50% drop in volume suggests reduced investor interest and liquidity concerns. The relative volume of 1.04 indicates slightly elevated activity, but the absolute numbers remain weak for a large-cap technology stock.

Liquidation Pressure: The negative momentum indicators point to forced selling. The Money Flow Index at 47.82 shows neutral sentiment, but the Commodity Channel Index at -224.12 signals extreme oversold conditions. The Awesome Oscillator at 1.49 and Rate of Change at -10.99% confirm sustained downward pressure. Bollinger Bands show the stock trading near the lower band at INR 238.05, suggesting potential support but continued weakness.

Financial Performance and Year-to-Date Decline

GENESYS.BO stock has suffered dramatically over longer timeframes. Year-to-date, the stock is down 47.56%, while the one-year decline reaches 66.96%. The 52-week high of INR 897.9 versus the current price represents a devastating 75.6% loss. Even the 52-week low of INR 227.1 sits above today’s close, showing continued deterioration.

Growth metrics reveal operational challenges. Revenue growth stands at 56.89%, but net income growth of 154.72% masks quality concerns. Operating cash flow declined 406.54% year-over-year, indicating severe cash generation problems. The company’s return on equity of 6.79% and return on assets of 4.26% lag sector averages. Track GENESYS.BO on Meyka for real-time updates on this deteriorating situation.

Advertisement

Final Thoughts

GENESYS.BO stock’s 16.87% crash on May 12, 2026 reflects serious fundamental and technical deterioration. Genesys International Corporation Limited faces mounting challenges including negative free cash flow, weak profitability metrics, and a strong sell rating from Meyka AI’s analysis framework. The stock’s collapse below key moving averages and extreme oversold technical indicators suggest further weakness ahead. Investors should note the company’s earnings announcement scheduled for May 28, 2026, which may provide clarity on operational performance. These grades are not guaranteed and we are not financial advisors. The combination of poor cash flow generation, declining year-over-year …

FAQs

Why did GENESYS.BO stock fall 16.87% on May 12, 2026?

The stock crashed due to negative free cash flow of INR -6.41 per share and weak profitability. Technical indicators showed extreme oversold conditions with RSI at 38.24 and Williams %R at -96.23.

What is the current price and market cap of GENESYS.BO?

GENESYS.BO closed at INR 219.1 on May 12, 2026, with a market cap of INR 9.6 billion, down INR 44.45 from the previous close.

Is GENESYS.BO stock a buy at current levels?

Meyka AI rates GENESYS.BO with a D+ rating and Strong Sell recommendation due to negative operating cash flow, weak ROE of 6.79%, and PE ratio of 15.78.

When is Genesys International’s next earnings announcement?

Genesys International will announce earnings on May 28, 2026 at 10:59 AM UTC, potentially clarifying operational performance and cash flow issues.

What are the key technical support levels for GENESYS.BO?

Immediate support is at INR 217.05. Bollinger Band support is at INR 238.05. The 200-day and 50-day moving averages are at INR 549.67 and INR 393.13 respectively.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)